Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Regenerative Medicine with iPS Cells Finally Turns to Kidney Applications

Filed Under: Innovation Tagged With: , , , , , , , , ,

The pharmaceutical sector has finally started up R&D efforts aimed at using induced pluripotent stem (iPS) cells to regenerate internal…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
U.S.–Japanese Research Team Creates Multi-Organ Structure From Human iPS Cells
U.S.–Japanese Research Team Creates Multi-Organ Structure…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments
Coronavirus Report – Part 13: Japanese Companies Start to…